| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 7 |
| 1 | METHOTREXATE SODIUM | 7 |
| 2 | ADALIMUMAB | 6 |
| 3 | METHOTREXATE | 6 |
| 4 | ADALIMUMAB-AATY | 5 |
| 5 | ADALIMUMAB-ADAZ | 5 |
| 6 | ADALIMUMAB-FKJP | 5 |
| 7 | CANAKINUMAB | 1 |
| 8 | CARBOPLATIN | 1 |
| 9 | CYCLOPHOSPHAMIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-FKJP | 5 | 0.0001 |
| 1 | THIOTEPA | 1 | 0.0001 |
| 2 | ADALIMUMAB-AATY | 5 | 0.0001 |
| 3 | CANAKINUMAB | 1 | 0.0001 |
| 4 | ADALIMUMAB-ADAZ | 5 | 0.0001 |
| 5 | INFLIXIMAB | 7 | 0.0000 |
| 6 | METHOTREXATE SODIUM | 7 | 0.0000 |
| 7 | ETOPOSIDE | 1 | 0.0000 |
| 8 | ADALIMUMAB | 6 | 0.0000 |
| 9 | CARBOPLATIN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 6 |
| 2 | Alkylating Drug [EPC] | 1 |
| 3 | Corticosteroid [EPC] | 1 |
| 4 | Platinum-based Drug [EPC] | 1 |
| 5 | Topoisomerase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 1 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 7 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 1 | 0.0000 |